Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

Certara2026 年 7 月 20 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

Certara2026 年 7 月 16 日

Webinar

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Jan Christopherson2026 年 7 月 14 日

Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Certara2026 年 7 月 13 日

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Certara2026 年 7 月 13 日

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara2026 年 7 月 9 日

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026 年 7 月 7 日

On-Demand Webinar

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…

Certara2026 年 7 月 1 日

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Certara2026 年 6 月 26 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

药物开发

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

EANM 2026

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Enhancing clinical trials with real-world evidence in pregnancy research

订阅时事通讯

快捷链接

解决方案

联系我们